Microfluidics & lab-on-chip research lab

Our lab, offers quality research, training, consultancy, and contract R&D in the area of Microfluidics & lab-on-chip. Research Themes Examples: • Manufacturing of polymer-based (e.g., PLGA), lipid-based (e.g., liposomes, Solid lipid nanoparticles, niosomes, exosomes), hydrid, supramolecular assembly, metal-based (e.g., Au), and Nanocrystalline Nanomedicines using microfluidics and comparison with traditional formulation methods (e.g., extrusion, high-pressure homogenization, thin-film hydration). • Manufacturing of Nanoparticles for imaging, treatment or targeting. Including, surface modification for cancer treatment and targeting. • Encapsulation of new or currently available drugs & biologics, including the encapsulation of therapeutic nucleic acids (e.g., microRNA, siRNA). • Microfluidics for drug discovery and development. • Microfluidic devices for precise drug delivery. • Microfluidics for point-of-care (PoC) diagnostic devices. • Microfluidic technology for rapid and effective detection of food allergens, detection of viral infections, or tumors (cancer). • In-house fabrication of microfluidic chips by: 3D Printing & Bioprinting, and injection molding. Studies include: conceptualization, formulation of nanomedicines, manufacturing of chips by 3D printing & Bioprinting technologies, advanced physicochemical characterization, computational modelling (e.g., Finite Element Analysis (FEA), Computational Fluid Dynamics (CFD)), in vivo, ex vivo, and in vitro evaluation. Our Lab, has been recognized as world leaders in Microfluidics. PubMed-based algorithms placed us in the top 0.07% of scholars in the world writing about Microfluidics, over the past 10 years. The lab has achieved a high level of sustainability by successfully implementing the recommendations in the Laboratory Efficiency Assessment Framework (LEAF) pilot program and has been recognized for its efforts with a Gold Award.